Alzheimer's disease drug development pipeline: 2023
Alzheimer s & Dementia Translational Research & Clinical Interventions2023Vol. 9(2), pp. e12385–e12385
Citations Over TimeTop 1% of 2023 papers
Abstract
There are currently 187 trials assessing 141 drugs for the treatment of Alzheimer's disease (AD).Drugs in the AD pipeline address a variety of pathological processes.More than 57,000 participants will be required to populate all currently registered trials.
Related Papers
- → Proposed Pipeline Clocking Scheme for Microarchitecture Data Propagation Delay Minimization(2020)2 cited
- An Approach to the Automated Evaluation of Pipeline Architectures in Natural Language Dialogue Systems(2011)
- Feasibility of Application of Repaired Pipeline on Surface Gathering Pipeline(2015)
- → People's Drug Guide to Deadly Drug Interactions Focuses on Drug/Drug, Drug/Food, and Drug/Vitamin Interactions(1998)
- → Inter Pipeline to expand Mid-Saskatchewan pipeline system(2014)